Literature DB >> 21899558

Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL.

G A C Dias1, G V Pires, S O R Valle, A T França, J A Papi, S D Dortas, S A P Levy, I Baiardini, G W Canonica.   

Abstract

BACKGROUND: Chronic urticaria (CU) is a debilitating skin disorder that affects patients' health related quality of life and the only questionnaire prepared specifically to CU is the Chronic Urticaria Quality of Life Questionnaire (CU-Q(2)oL).
OBJECTIVE: The purpose of this study was to cross-culturally adapt and validate the CU-Q(2)oL Brazilian-Portuguese version.
METHODS: Forward and back translation by three bilingual translators followed by pre-test was used to adapt the questionnaire. The CU-Q(2)oL was self-administered along with the Dermatology Life Quality Index (DLQI) in 112 patients with CU. Disease activity was assessed using the Urticaria Activity Score. Factor analysis was used to identify scales of the Brazilian portuguese CU-Q(2)oL. Internal consistency, convergent validity and known-group validity was determined. Reproducibility was evaluated by interclass correlation coefficient (ICC). Multiple linear regression was used to determine the predicting factors of CU-Q(2)oL results.
RESULTS: Factor analysis revealed a three-dimensional structure: sleep/mental status/eating (I), pruritus/impact on life activities (II) and swelling/limits/look (III), which explained 52.49% of the total variance. All scales showed excellent internal consistency. External construct validity was supported by correlations between the CU-Q(2)oL and DLQI. The tool was found to be able to differentiate between patients with high and low levels of urticaria activity. Test-retest reliability was good to excellent (ICC = 0.69-0.86). Disease severity and urticaria type were the only factors predicting results.
CONCLUSIONS: The CU-Q(2)oL Brazilian portuguese version was easily filled out, well accepted by the patients, demonstrated an acceptable validity and reliability and might be used to evaluate treatment outcomes and in clinical research.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21899558     DOI: 10.1111/j.1398-9995.2011.02695.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

Review 1.  Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Marcus Maurer; Kilian Eyerich; Stefanie Eyerich; Marta Ferrer; Jan Gutermuth; Karin Hartmann; Thilo Jakob; Alexander Kapp; Pavel Kolkhir; Désirée Larenas-Linnemann; Hae-Sim Park; Gunnar Pejler; Mario Sánchez-Borges; Knut Schäkel; Dagmar Simon; Hans-Uwe Simon; Karsten Weller; Torsten Zuberbier; Martin Metz
Journal:  Int Arch Allergy Immunol       Date:  2020-03-30       Impact factor: 2.749

2.  Translation and validation of Portuguese of a questionnaire for evaluation of psychosomatic symptoms in adults with atopic dermatitis.

Authors:  Manuela Boleira; Omar Lupi; Gisele Vianna Pires; Gabriela Dias; Amanda Jaccobson Seba; Daniel Boleira Sieiro Guimarães
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

3.  Impact of chronic urticaria on the quality of life of patients followed up at a university hospital.

Authors:  Gabriela Andrade Coelho Dias; Gisele Viana Pires; Solange Oliveira Rodrigues do Valle; Sérgio Duarte Dortas; Soloni Levy; Alfeu Tavares França; Ilaria Baiardini; Walter Giorgio Canonica
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

4.  Why a registry of Chronic Urticaria (CUR) is needed.

Authors:  R M Gómez; E Jares; G W Canonica; I Baiardini; G Passalacqua; M Sánchez Borges; A P Kaplan; Carlos E Baena-Cagnani
Journal:  World Allergy Organ J       Date:  2017-05-16       Impact factor: 4.084

5.  Latin American chronic urticaria registry (CUR) contribution to the understanding and knowledge of the disease in the region.

Authors:  René Maximiliano Gómez; Edgardo Jares; Mario Sanchez Borges; Ilaria Baiardini; G Walter Canonica; Gianni Passalacqua; Allen Kaplan; Patricia Latour; Eduardo Costa; Gabriela Dias; Jorge Lavrut
Journal:  World Allergy Organ J       Date:  2019-06-13       Impact factor: 4.084

6.  Pathogenetic aspects of chronic urticaria. Retrospective and prospective analysis of the patients of the Department of Dermatology, Poznan University of Medical Sciences.

Authors:  Dorota Jenerowicz; Anna Błaszczyk; Filip Raciborski; Anna Sadowska-Przytocka; Zygmunt Adamski; Magdalena Czarnecka-Operacz
Journal:  Postepy Dermatol Alergol       Date:  2021-10-25       Impact factor: 1.664

7.  Psychometric properties of the portuguese version of the chronic urticaria quality of life questionnaire (CU-Q2oL).

Authors:  Pedro Lopes Ferreira; Margarida Gonçalo; José Alberto Ferreira; Ana Célia Costa; Ana Todo-Bom; Cristina Lopes Abreu; Ana Rita Travassos; Pedro Andrade; Ilaria Baiardini; Giorgio Walter Canonica
Journal:  Health Qual Life Outcomes       Date:  2019-12-30       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.